ANNX
ANNX
NASDAQ · Biotechnology

Annexon Inc

Small-Cap Stocks Stocks Under $10 Biotech Stocks Healthcare Stocks
$5.41
-0.19 (-3.39%)
As of Aug 8, 10:14 PM ET ·
Analyst Consensus
Strong Buy
17
Analysts
High
Coverage
Buy 14 82%
Hold 2 12%
Sell 1 6%
Price Target
Analyst Price Target +654.3% upside
Low Target $23.52
Average Target $40.81
High Target $51.70
Current Price $5.41
Current
$5.41
Target
$40.81
$23.52 $40.81 avg $51.70
Scenario Analysis
Bear Case
$23.52
334.8%
Low target
Base Case
$40.81
+654.3%
Avg target
Bull Case
$51.70
+855.6%
High target
Risk/Reward
2.6x
Favorable
Price in Context
52-Week High
$7.18
-24.7% from high
52-Week Low
$2.03
+166.5% from low
Target vs 52W High
$40.81
+468.4% vs high
Next Earnings Report
Aug 17, 2026
7d
until earnings
EPS Est: $-0.24
Earnings in 7 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 38 82% $257.58 +4.7%
AMGN
Amgen Inc
 Hold 43 49% $190.87 -53.6%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +172.3%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 37 81% $438.34 -11.6%
REGN
Regeneron Pharmaceuticals
 Buy 37 70% $76.80 -90.2%
NTRA
Natera Inc
 Strong Buy 30 87% $142.91 -55.6%
RVMD
Revolution Medicines Inc
 Strong Buy 28 93% $114.11 -44.4%
BIIB
Biogen Inc
 Buy 43 67% $91.45 -56.0%